Ozempic and Rybelsus are FDA-approved for lowering blood sugar levels in adults with type 2 diabetes
The administration redacted and withheld documents, saying they were draft records or recommendations, or pertained to personal privacy
In a large analysis , people with type 2 diabetes who took 1 mg of semaglutide lowered their A1c by an average of 1.77% after 26 weeks compared to 1.09% with the highest dose of metformin
The common side effects of these drugs include nausea, vomiting, diarrhea, and constipation
Regulatory Scrutiny Notice: The GLP-1 telehealth industry and compounded GLP-1 medications have been under active regulatory scrutiny
As of late 2024, only 14 state Medicaid programs cover GLP-1 drugs like Wegovy, Saxenda, or Zepbound for the treatment of obesity